- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07226167
Hearing Aid Benefit in Real-World Noisy Environments
February 20, 2026 updated by: University of Wisconsin, Madison
Evaluating the Impact of Hearing Aid Signal Enhancement Algorithms in Real-World Contexts
Researchers are doing this study to understand why hearing aids often work well in controlled laboratory settings but don't provide the same level of benefit in everyday noisy environments. The questions they hope to answer are:
- What factors contribute to hearing aid benefit in noisy environments
- What factors limit hearing aid benefit
- How do real-world factors interact with common hearing aid settings
Participants will complete:
- Hearing and listening tests
- Memory and attention assessment
- Surveys on their Smartphone
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
This is study investigates how hearing aid signal processing algorithms and environmental factors in listening situations interact to affect listening outcomes.
A crossover design is used to assess speech perception, listening effort, and user satisfaction across diverse acoustic contexts.
Study Type
Interventional
Enrollment (Estimated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lucas Modahl
- Email: lmodahl@wisc.edu
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- Recruiting
- University of Wisconsin - Madison
-
Contact:
- Lucas Modahl
- Email: lmodahl@wisc.edu
-
Principal Investigator:
- Erik Jorgensen, AuD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Over 18 years old
- Symmetrical, bilateral, adult onset, sensorineural hearing loss
- Experienced hearing aid users (> 3 months)
Exclusion Criteria:
- Under 18 years old
- Conductive or mixed hearing loss
- Asymmetrical or unilateral hearing loss
- Pre-lingual or childhood hearing loss onset
- No hearing aid experience
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hearing aid + smartphone surveys
Participants will use study-provided hearing aids
|
Participants will use study-provided hearing aids for 15 minutes, 7-10 times for a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compare effectiveness of hearing aid signal enhancement on speech perception
Time Frame: 1 week
|
Participants will hear 3 different, 5 minute listening scenarios and answer the same survey questions for each.
They will rate perception from 0% (understood nothing) to 100% (understood everything).
Percentages will be compared across the 3 scenarios.
|
1 week
|
|
Compare effectiveness of hearing aid signal enhancement on listening effort
Time Frame: 1 week
|
Participants will hear 3 different, 5 minute listening scenarios and answer the same survey questions for each.
They will rate how hard they had to work to understand what was said from 0% (no effort) to 100% (extremely hard).
Percentages will be compared across the 3 scenarios.
|
1 week
|
|
Compare effectiveness of hearing aid signal enhancement on listening comfort
Time Frame: 1 week
|
Participants will hear 3 different, 5 minute listening scenarios and answer the same survey questions for each.
They will rate how comfortable it was to listen from 0% (very comfortable) to 100% (very uncomfortable).
Percentages will be compared across the 3 scenarios.
|
1 week
|
|
Compare effectiveness of hearing aid signal enhancement on sound quality
Time Frame: 1 week
|
Participants will hear 3 different, 5 minute listening scenarios and answer the same survey questions for each.
They will rate the sound quality from 0% (very poor) to 100% (excellent).
Percentages will be compared across the 3 scenarios.
|
1 week
|
|
Compare effectiveness of hearing aid signal enhancement on sound location
Time Frame: 1 week
|
Participants will hear 3 different, 5 minute listening scenarios and answer the same survey questions for each.
They will rate how easy it was to tell where the sound was coming from, from 0% (could not tell) to 100% (very easy).
Percentages will be compared across the 3 scenarios.
|
1 week
|
|
Compare effectiveness of hearing aid algorithms based on location
Time Frame: 1 week
|
Participants will complete the same survey questions for all three algorithms.
Participants will select which option best describes the environment they are in when completing the hearing survey.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Erik Jorgensen, AuD, PhD, University of Wisconsin, Madison
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 19, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Study Registration Dates
First Submitted
November 3, 2025
First Submitted That Met QC Criteria
November 3, 2025
First Posted (Actual)
November 10, 2025
Study Record Updates
Last Update Posted (Actual)
February 24, 2026
Last Update Submitted That Met QC Criteria
February 20, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Otorhinolaryngologic Diseases
- Sensation Disorders
- Ear Diseases
- Hearing Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Hearing Loss
- Equipment and Supplies
- Electrical Equipment and Supplies
- Wearable Electronic Devices
- Sensory Aids
- Hearing Aids
Other Study ID Numbers
- 2025-1586
- FA (Other Identifier: UW Madison)
- UWMSN | L&S | Communication Sc (Other Identifier: UW Madison)
- Protocol Version 11/25/25 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Adult-Onset
-
Archean TechnologiesRecruiting
-
Radboud University Medical CenterRecruitingHearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Adult-Onset | Hearing Loss, Bilateral Sensorineural, ProgressiveNetherlands
-
Matthew Bush, MDNational Institutes of Health (NIH); National Institute on Deafness and Other...RecruitingHearing Loss, Adult-Onset | Hearing Loss, Age-RelatedUnited States
-
University of Southern CaliforniaNot yet recruiting
-
The University of Texas at DallasRecruiting
-
Royal Cornwall Hospitals TrustUniversity of Birmingham; University of ExeterNot yet recruitingTinnitus | Hearing Loss, Adult-OnsetUnited Kingdom
-
Craig D. Workman, PhDRecruitingSpeech Intelligibility | Hearing Loss, Adult-Onset | Hearing Loss, ExtremeUnited States
-
PediatrixCompletedHearing Loss | Deafness | Late-Onset Hearing LossUnited States
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
Clinical Trials on Hearing aid
-
Northwestern UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
Sonova AGCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralCanada
-
Bernafon AGCompletedHearing LossSwitzerland
-
HearX SAWithdrawnHearing Loss | Hearing Impairment
-
Sonova AGCompleted
-
Sonova AGWestern UniversityRecruiting
-
Sonova AGCompleted
-
Purdue UniversityRecruiting